Bullish option flow detected in Altimmune (ALT) with 13,503 calls trading, 4x expected, and implied vol increasing over 44 points to 140.99%. Mar-25 6 calls and 3/14 weekly 6 calls are the most active options, with total volume in those strikes near 6,400 contracts. The Put/Call Ratio is 0.19. Earnings are expected on May 15th.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT:
- Evercore bullish on Altimmune, likes drug move into alcohol related disease
- Promising Potential of Altimmune’s Pemvidutide Drives Buy Rating Amid Expanding Indications and Strong Market Outlook
- Altimmune’s Pemvidutide: Promising Future with IMPACT Trial and Market Expansion
- Altimmune’s Earnings Call: Progress Amid Challenges
- Altimmune Reports Progress in Clinical Trials and Financials